Works by Maurer, Matthew J.
Results: 99
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
- By:
- Publication type:
- Article
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01080-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0271-z
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0220-x
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy.
- Published in:
- Clinical Epidemiology, 2019, v. 11, p. 987, doi. 10.2147/CLEP.S219595
- By:
- Publication type:
- Article
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224564
- By:
- Publication type:
- Article
Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Degradation Signals for Ubiquitin-Proteasome Dependent Cytosolic Protein Quality Control (CytoQC) in Yeast.
- Published in:
- G3: Genes | Genomes | Genetics, 2016, v. 6, n. 7, p. 1853, doi. 10.1534/g3.116.027953
- By:
- Publication type:
- Article
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
- Published in:
- Nutrition & Cancer, 2018, v. 70, n. 7, p. 1088, doi. 10.1080/01635581.2018.1502328
- By:
- Publication type:
- Article
Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 12, p. 2993, doi. 10.1002/cncr.25114
- By:
- Publication type:
- Article
A Phase 2 Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 8, p. 1772, doi. 10.1002/cncr.23313
- By:
- Publication type:
- Article
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2826, doi. 10.1002/cncr.22342
- By:
- Publication type:
- Article
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
- By:
- Publication type:
- Article
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 149, doi. 10.1111/bjh.14922
- By:
- Publication type:
- Article
Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 5, p. 644, doi. 10.1111/bjh.15416
- By:
- Publication type:
- Article
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 50, doi. 10.1111/bjh.14813
- By:
- Publication type:
- Article
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 85, doi. 10.1111/bjh.13399
- By:
- Publication type:
- Article
Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3233
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 39, doi. 10.1002/hon.3098
- By:
- Publication type:
- Article
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3390, doi. 10.1002/cncr.33660
- By:
- Publication type:
- Article
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 2, p. 156, doi. 10.1215/15228517-2005-005
- By:
- Publication type:
- Article
Reversing the restrictive trend in diffuse large B‐cell lymphoma trial eligibility: it's time to open the gates!
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 697, doi. 10.1111/bjh.17433
- By:
- Publication type:
- Article
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 661, doi. 10.1111/bjh.16425
- By:
- Publication type:
- Article
Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. 820, doi. 10.1111/bjh.15997
- By:
- Publication type:
- Article
Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. e24, doi. 10.1111/bjh.15859
- By:
- Publication type:
- Article
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 583, doi. 10.1002/ajh.25783
- By:
- Publication type:
- Article
Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 786, doi. 10.1002/ajh.25493
- By:
- Publication type:
- Article
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non‐follicular indolent B‐cell lymphomas.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. 658, doi. 10.1002/ajh.25473
- By:
- Publication type:
- Article
Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
- By:
- Publication type:
- Article
Prevalence, clinical characteristics and prognosis of EBV‐positive follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 2, p. E62, doi. 10.1002/ajh.25357
- By:
- Publication type:
- Article
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
- By:
- Publication type:
- Article
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 752, doi. 10.1002/ajh.24758
- By:
- Publication type:
- Article
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
- By:
- Publication type:
- Article